Two Can Play at That Game
So Rush Limbaugh has the audacity to deem a Georgetown law student who called for mandatory insurance coverage of contraception a "slut" and a "prostitute."
Those are pretty harsh terms for someone who has a clear history of being a drug addict and a junkie.
Labels: drugs, Rush Limbaugh, stupid pundit tricks
Medical News Flash
Here is a news flash for anyone under the delusion that the letters "M.D." after someone's name made them automagically the paragon of medical ethics.
First, a tiny sliver of data reveals that lots of doctors make lots of money from consulting for pharmaceutical companies. Not that money would ever, ever, influence their behavior.
Minnesota [was] the first of a handful of states to pass a law requiring drug makers to disclose payments to doctors. The Minnesota records are a window on the widespread financial ties between pharmaceutical companies and the doctors who prescribe and recommend their products. Patient advocacy groups and many doctors themselves have long complained that drug companies exert undue influence on doctors, but the extent of such payments has been hard to quantify.
The Minnesota records begin in 1997. From then through 2005, drug makers paid more than 5,500 doctors, nurses and other health care workers in the state at least $57 million. Another $40 million went to clinics, research centers and other organizations. More than 20 percent of the state’s licensed physicians received money. The median payment per consultant was $1,000; more than 100 people received more than $100,000.
And we also find that the Federal Food and Drug Administration wants to limit its advisers to get only $50,000 from a company to serve on its advisory committees. (For reference, in 2005, the per capita income in the United States was only $25,036.)
Expert advisers to the government who receive money from a drug or device maker would be barred for the first time from voting on whether to approve that company's products under new rules announced Wednesday for the F.D.A.'s powerful advisory committees.
Indeed, such doctors who receive more than $50,000 from a company or a competitor whose product is being discussed would no longer be allowed to serve on the committees, though those who receive less than that amount in the prior year can join a committee and participate in its discussions.
A "significant number" of the agency's present advisers would be affected by the new policy, said the F.D.A. acting deputy commissioner, Randall W. Lutter, though he would not say how many. The rules are among the first major changes made by Dr. Andrew C. von Eschenbach since he was confirmed as commissioner of food and drugs late last year.
Labels: doctors, drugs, FDA, greedheads